PPH vs XPH
VanEck Pharmaceutical ETF against State Street SPDR S&P Pharmaceuticals ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
18%
14 shared positions
Fee gap
1 bp
XPH is cheaper
1-year return gap
15.2 pts
XPH is ahead
Larger fund
PPH
$1.0B
Side by side
| PPH | XPH | |
|---|---|---|
| Fund | VanEck Pharmaceutical ETF | State Street SPDR S&P Pharmaceuticals ETF |
| Issuer | VanEck | State Street SPDR |
| Category | Health Care | Health Care |
| Expense ratio | 0.36% | 0.35% |
| Assets | $1.0B | $462M |
| Average daily dollar volume | $32M | $15M |
| Listed | Dec 20, 2011 | Jun 19, 2006 |
| FrenzyCap score | 62 | 70 |
| 1-month return | +0.8% | −4.9% |
| 3-month return | +1.6% | −3.3% |
| Year to date | +7.1% | +15.4% |
| 1-year return | +18.3% | +33.5% |
| 30-day volatility | 16.1% | 21.3% |
| Worst drawdown, 1 year | −11.5% | −15.1% |
| Trailing 12-month yield | 1.94% | 0.42% |
| Holdings | 27 | 62 |
| Top 10 weight | 71.5% | 22.7% |
| Look-through P/E | 39.0 | — |
| Holdings vs fair value | +5.2% | +18.3% |
| Holdings above 200-day average | 67% | 59% |
| Net flow, latest 3 reported months | −$449M thru Jun 2026 | +$47M thru Jun 2026 |
| 30-day implied volatility | 20.7% | 28.4% |
| Holdings as of | as of Oct 8, 2026issuer data | as of Oct 8, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
55% of PPH · 28% of XPH
Sector mix of the stock holdings
| Sector | PPH | XPH | Gap |
|---|---|---|---|
| Health Care | 96.1% | 99.2% | −3.0% |
| Consumer Staples | 3.8% | 0.0% | +3.8% |
| Technology | 0.0% | 0.8% | −0.8% |
More: full overlap table · PPH holdings · XPH holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.